Terms: = Breast cancer AND LCP1, CP64, 3936, ENSG00000136167, FLJ39956, DKFZp781A23186, L-PLASTIN, FLJ25423, P13796, FLJ26114, PLS2, LC64P AND Treatment
11 results:
1. Estimating the Product Lifecycle Value of Trastuzumab Based on Registry Data in Sweden.
Justo N; Wilking N; Jönsson L
Clin Drug Investig; 2023 Jul; 43(7):529-540. PubMed ID: 37422544
[TBL] [Abstract] [Full Text] [Related]
2. GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells.
Inaguma S; Riku M; Ito H; Tsunoda T; Ikeda H; Kasai K
Oncotarget; 2015 Oct; 6(32):33648-57. PubMed ID: 26413813
[TBL] [Abstract] [Full Text] [Related]
3. Proteotranscriptomic Profiling of 231-BR breast cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.
Dun MD; Chalkley RJ; Faulkner S; Keene S; Avery-Kiejda KA; Scott RJ; Falkenby LG; Cairns MJ; Larsen MR; Bradshaw RA; Hondermarck H
Mol Cell Proteomics; 2015 Sep; 14(9):2316-30. PubMed ID: 26041846
[TBL] [Abstract] [Full Text] [Related]
4. Quantitative kinetic study of the actin-bundling protein l-plastin and of its impact on actin turn-over.
Al Tanoury Z; Schaffner-Reckinger E; Halavatyi A; Hoffmann C; Moes M; Hadzic E; Catillon M; Yatskou M; Friederich E
PLoS One; 2010 Feb; 5(2):e9210. PubMed ID: 20169155
[TBL] [Abstract] [Full Text] [Related]
5. Identification of differentially expressed proteins in triple-negative breast carcinomas using DIGE and mass spectrometry.
Schulz DM; Böllner C; Thomas G; Atkinson M; Esposito I; Höfler H; Aubele M
J Proteome Res; 2009 Jul; 8(7):3430-8. PubMed ID: 19485423
[TBL] [Abstract] [Full Text] [Related]
6. Cataracts among cancer survivors.
Stava C; Beck M; Vassilopoulou-Sellin R
Am J Clin Oncol; 2005 Dec; 28(6):603-8. PubMed ID: 16317272
[TBL] [Abstract] [Full Text] [Related]
7. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians' and nurses' estimation vs. patients' reported outcomes.
Liau CT; Chu NM; Liu HE; Deuson R; Lien J; Chen JS
Support Care Cancer; 2005 May; 13(5):277-86. PubMed ID: 15770489
[TBL] [Abstract] [Full Text] [Related]
8. Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms.
Akbulut H; Tang Y; Maynard J; Zhang L; Pizzorno G; Deisseroth A
Clin Cancer Res; 2004 Nov; 10(22):7738-46. PubMed ID: 15570008
[TBL] [Abstract] [Full Text] [Related]
9. Cytotoxic effect of replication-competent adenoviral vectors carrying l-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract] [Full Text] [Related]
10. Adenoviral vectors with E1A regulated by tumor-specific promoters are selectively cytolytic for breast cancer and melanoma.
Zhang L; Akbulut H; Tang Y; Peng X; Pizzorno G; Sapi E; Manegold S; Deisseroth A
Mol Ther; 2002 Sep; 6(3):386-93. PubMed ID: 12231175
[TBL] [Abstract] [Full Text] [Related]
11. Use of l-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract] [Full Text] [Related]
